Trial Review

Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements. New passwords must include at least one lowercase letter, one uppercase letter, one number and one special character (e.g. !#$%&@).
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02892058




Registration number
NCT02892058
Ethics application status
Date submitted
23/08/2016
Date registered
8/09/2016
Date last updated
8/02/2023

Titles & IDs
Public title
Self-assessment of Flare in Osteoarthritis of Lower Limbs
Scientific title
Development of a Tool for the Self-assessment of Flare in Patients With Osteoarthritis of Lower Limbs
Secondary ID [1] 0 0
FLARE-OA
Universal Trial Number (UTN)
Trial acronym
FLARE-OA
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Osteoarthritis 0 0
Condition category
Condition code
Musculoskeletal 0 0 0 0
Osteoarthritis

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Ability of a FLARE-OA self-questionnaire to detect flare episodes in knee or hip osteoarthritis
Assessment method [1] 0 0
patient-reported outcome questionnaire for the self-assessment of flare in osteoarthritis. The questionnaire will be developed during the first part of the study.
Timepoint [1] 0 0
Baseline
Primary outcome [2] 0 0
Change in ability of a FLARE-OA self-questionnaire to detect flare episodes in knee or hip osteoarthritis during a 6 months period
Assessment method [2] 0 0
patient-reported outcome questionnaire for the self-assessment of flare in osteoarthritis. The questionnaire will be developed during the first part of the study.
Timepoint [2] 0 0
At 3 and 6 month follow-up
Secondary outcome [1] 0 0
Evolution of the quality of life during a 6 months period with the standardized OAKHQOL questionnaire
Assessment method [1] 0 0
Osteoarthritis knee and hip quality of life questionnaire (OAKHQOL) self-assessment questionnaire
Timepoint [1] 0 0
up to 3 and 6 month
Secondary outcome [2] 0 0
Evolution of the functional limitation related to knee osteoarthritis during a 6 months period with the standardized KOOS questionnaire
Assessment method [2] 0 0
Knee injury and Osteoarthritis Outcome Score (KOOS) patient questionnaire. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4.
Timepoint [2] 0 0
up to 3 and 6 month
Secondary outcome [3] 0 0
Evolution of the functional limitation related to hip osteoarthritis during a 6 months period with the standardized HOOS questionnaire
Assessment method [3] 0 0
Hip disability and Osteoarthritis Outcome Score (HOOS) patient questionnaire. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4.
Timepoint [3] 0 0
up to 3 and 6 month
Secondary outcome [4] 0 0
Pain intensity measure
Assessment method [4] 0 0
Self-reported pain intensity using a numerical rating scale
Timepoint [4] 0 0
up to 3 and 6 month

Eligibility
Key inclusion criteria
* with clinical and radiological hip or knee OA confirmed by a physician,
* whatever their status regarding flare of OA. The intention of the Flare-OA tool is not to detect current flare only, but also a flare that may have occurred before the encounter with the health care professional. Therefore patient will not be selected on flare, and patients with flare will not be excluded.
Minimum age
45 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Patients who never experienced nor currently report having a flare of OA
* Patients with both hip and knee OA

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/04/2015
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/12/2022
Sample size
Target
Accrual to date
Final
398
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Institute of Bone and Joint Research - University of Sydney - Sydney
Recruitment postcode(s) [1] 0 0
- Sydney
Recruitment outside Australia
Country [1] 0 0
Canada
State/province [1] 0 0
Toronto
Country [2] 0 0
France
State/province [2] 0 0
Besançon
Country [3] 0 0
France
State/province [3] 0 0
Brest
Country [4] 0 0
France
State/province [4] 0 0
Dijon
Country [5] 0 0
France
State/province [5] 0 0
Grenoble
Country [6] 0 0
France
State/province [6] 0 0
Nantes
Country [7] 0 0
France
State/province [7] 0 0
Paris
Country [8] 0 0
France
State/province [8] 0 0
Poitiers
Country [9] 0 0
France
State/province [9] 0 0
Vandoeuvre-les-Nancy
Country [10] 0 0
Martinique
State/province [10] 0 0
Fort-de-France

Funding & Sponsors
Primary sponsor type
Other
Name
Central Hospital, Nancy, France
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Francis GUILLEMIN
Address 0 0
CHRU NANCY, CIC 1433 Epidémiologie Clinique
Country 0 0
Phone 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents


Results not provided in https://clinicaltrials.gov/study/NCT02892058